These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 29192575)
21. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. Legrand-Abravanel F; Kamar N; Sandres-Saune K; Garrouste C; Dubois M; Mansuy JM; Muscari F; Sallusto F; Rostaing L; Izopet J J Infect Dis; 2010 Sep; 202(6):835-44. PubMed ID: 20695798 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors. Pisano MB; Balderramo D; Wassaf MM; Lotto M; Carlino Y; Ré VE; Debes JD Arch Virol; 2017 Mar; 162(3):787-792. PubMed ID: 27885564 [TBL] [Abstract][Full Text] [Related]
23. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. Moal V; Legris T; Burtey S; Morange S; Purgus R; Dussol B; Garcia S; Motte A; Gérolami R; Berland Y; Colson P J Med Virol; 2013 Mar; 85(3):462-71. PubMed ID: 23239466 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Pischke S; Suneetha PV; Baechlein C; Barg-Hock H; Heim A; Kamar N; Schlue J; Strassburg CP; Lehner F; Raupach R; Bremer B; Magerstedt P; Cornberg M; Seehusen F; Baumgaertner W; Klempnauer J; Izopet J; Manns MP; Grummer B; Wedemeyer H Liver Transpl; 2010 Jan; 16(1):74-82. PubMed ID: 19866448 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis E virus and blood transfusion safety. Bi H; Yang R; Wu C; Xia J Epidemiol Infect; 2020 Jun; 148():e158. PubMed ID: 32594963 [TBL] [Abstract][Full Text] [Related]
26. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Sayed IM; Foquet L; Verhoye L; Abravanel F; Farhoudi A; Leroux-Roels G; Izopet J; Meuleman P Antiviral Res; 2017 May; 141():150-154. PubMed ID: 28232247 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Versluis J; Pas SD; Agteresch HJ; de Man RA; Maaskant J; Schipper ME; Osterhaus AD; Cornelissen JJ; van der Eijk AA Blood; 2013 Aug; 122(6):1079-86. PubMed ID: 23794068 [TBL] [Abstract][Full Text] [Related]
28. [An update on hepatitis E]. Hiroz P; Gouttenoire J; Dao Thi VL; Sahli R; Telenti A; Moradpour D; Doerig C Rev Med Suisse; 2013 Sep; 9(396):1594, 1596-8. PubMed ID: 24066468 [TBL] [Abstract][Full Text] [Related]
29. [Hepatitis E in patients with hematological disorders]. Okamoto H Rinsho Ketsueki; 2018; 59(10):1914-1923. PubMed ID: 30305492 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States. Koning L; Charlton MR; Pas SD; Heimbach JK; Osterhaus AD; Watt KD; Janssen HL; de Knegt RJ; van der Eijk AA BMC Infect Dis; 2015 Sep; 15():371. PubMed ID: 26328802 [TBL] [Abstract][Full Text] [Related]
31. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. Schlosser B; Stein A; Neuhaus R; Pahl S; Ramez B; Krüger DH; Berg T; Hofmann J J Hepatol; 2012 Feb; 56(2):500-2. PubMed ID: 21798217 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis E virus infection--a new threat for Europe. Łapiński TW; Jaroszewicz J Przegl Epidemiol; 2016; 70(1):11-4, 103-6. PubMed ID: 27344467 [TBL] [Abstract][Full Text] [Related]
33. Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention. Goel A; Aggarwal R Expert Rev Gastroenterol Hepatol; 2016 Sep; 10(9):1065-74. PubMed ID: 27148907 [TBL] [Abstract][Full Text] [Related]
34. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation. van der Eijk AA; Pas SD; de Man RA Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):143-150. PubMed ID: 28624102 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised. Maylin S; Stephan R; Molina JM; Peraldi MN; Scieux C; Nicand E; Simon F; Delaugerre C J Clin Virol; 2012 Apr; 53(4):346-9. PubMed ID: 22293627 [TBL] [Abstract][Full Text] [Related]
37. Chronic hepatitis E in solid-organ transplantation: the key implications of immunosuppressants. Wang Y; Metselaar HJ; Peppelenbosch MP; Pan Q Curr Opin Infect Dis; 2014 Aug; 27(4):303-8. PubMed ID: 24977682 [TBL] [Abstract][Full Text] [Related]
38. Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study. Sadik S; van Rijckevorsel GG; van Rooijen MS; Sonder GJ; Bruisten SM BMC Infect Dis; 2016 Nov; 16(1):659. PubMed ID: 27825308 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis E virus infection in the HIV-positive patient. Debes JD; Pisano MB; Lotto M; Re V J Clin Virol; 2016 Jul; 80():102-6. PubMed ID: 27243210 [TBL] [Abstract][Full Text] [Related]